Johnson & Johnson Tops Q1 Estimates, Lifts Full-Year Sales Outlook
1. JNJ reported Q1 earnings of $2.77 EPS on $21.89 billion revenue. 2. Sales forecast raised to $91.0-$91.8 billion for the year. 3. Shares up about 1% post-report, 7% increase this year. 4. EPS forecast remains at $10.50 to $10.70 despite acquisitions. 5. Company aims to increase U.S. investment to $55 billion in four years.